Catherine Avery Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.35M Buy
17,530
+1,655
+10% +$567K 2.77% 15
2026
Q1
$5.59M Buy
15,875
+3,336
+27% +$1.19M 2.5% 24
2025
Q4
$4.1M Sell
12,539
-1,061
-8% -$337K 2.46% 25
2025
Q3
$3.84M Buy
13,600
+3,550
+35% +$1.03M 2.47% 24
2025
Q2
$2.81M Buy
+10,050
New +$2.85M 2.13% 31

Other funds holding AMGN

Catherine Avery Investment Management's AMGN Position: Q2 2026 in Review

Catherine Avery Investment Management increased its Amgen (AMGN) stake by 10% in Q2 2026, buying an estimated $567K and bringing the position to 17,530 shares worth $6.35M. The position accounts for 2.77% of the portfolio, ranked #15.

Catherine Avery Investment Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Catherine Avery Investment Management held 17,530 shares of Amgen worth $6.35M as of Q2 2026.
  • Catherine Avery Investment Management bought 1,655 Amgen shares in Q2 2026, an estimated $567K.
  • Amgen made up 2.77% of Catherine Avery Investment Management's portfolio in Q2 2026, its #15 holding.
  • Catherine Avery Investment Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Catherine Avery Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.